Adult Clinical Trial - An Intervention to Develop Interface Tools for

Status Active, not recruiting

Clinical Trial Summary

This study compares the efficacy of a non-practitioner assisted direct-to-consumer (DTC) self-driven approach to nutrigenomics versus a personalized practitioner-led method. The secondary aims are to use this data combined with participant feedback to generate more effective nutrigenomics-based products.

Clinical Trial Description

While nutrition is a widely accepted tool for the prevention of long-term health conditions, current approaches have not adequately reduced chronic disease morbidity. Nutrigenomics has great potential, however, it is complicated to implement. There is a need for products, derived from nutrigenomics, which are easily understood, accessible and utilized. The primary objective of this study is to compare the efficacy of a non-practitioner assisted direct-to-consumer (DTC) self-driven approach to nutrigenomics versus a personalized practitioner-led method. The secondary aims are to use this data combined with participant feedback to generate more effective nutrigenomics-based products.

Methods:

This 4-month study used a mixed-methods design that included: 1) a phase 1 randomized control trial that examined the effectiveness of a multi-faceted, nutrition-based gene test (components assessed included the major nutrients, food tolerances, food taste and preferences, and vitamins) in changing health behaviours; followed by 2) qualitative investigation that explored participants' experiences. The study recruited 57 healthy males and females (35-55 years) randomized as a 2:1 ratio where 38 received the intervention (gene-test results plus personalized nutrition report) and 19 were assigned to the control group (gene-test results report emailed). Both groups received follow-up emails with nutrition-related tips and reminders. The primary outcomes of interest measures included changes in diet (nutrients, healthy eating index), self-efficacy, quality of life and anthropometrics (BMI, waist:hip) measured at baseline, post-intervention (3 and 6 weeks), and the final visit. After the study has been completed, participants in the control group will also receive their personalized nutrition report. ;

Study Design

Related Conditions & MeSH terms

Adult

Clinical Trial Details

NCT number	NCT03310814
Study type	Interventional
Source	Kwantlen Polytechnic University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	March 15, 2017
Completion date	December 31, 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06320626` - Pharmacokinetic-guided Dosing of Emicizumab	Phase 4
Recruiting	`NCT05841667` - Impact of CES1 Genotype on Remimazolam
Completed	`NCT06355817` - Distraction Techniques in Periocular Anesthesia: Tapping vs Vibration	N/A
Not yet recruiting	`NCT01209481` - Impact of Educational Group Intervention on the Consumption of Fruit and Vegetables	N/A
Terminated	`NCT01570465` - Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients
Completed	`NCT04169646` - Prevention and Intervention of Neck Pain in Swiss Office-Workers	N/A
Not yet recruiting	`NCT01943565` - Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study	Phase 4
Completed	`NCT00519298` - Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects	Phase 1
Completed	`NCT03541837` - Erector Spinae Plane Block and Pain Management in Cardiac Surgery	N/A
Active, not recruiting	`NCT00809575` - Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes
Completed	`NCT05012046` - Effect of 100% Orange Juice on Food Intake and Glycemic Response in Adults	N/A
Completed	`NCT05597969` - The Effect of an Application-based Health Intervention (FoodCoach) on Food Purchases in Switzerland	N/A
Terminated	`NCT01817153` - Effect of Hydrocortison on Post-ischemic Flow-mediated Dilation and on Thenar Oxygen Saturation in Human Septic Shock.	Phase 2/Phase 3
Not yet recruiting	`NCT05123352` - Investigation of the Gut Microbiota in Acute Myeloid Leukemia Receiving Two Different Induction Therapies
Not yet recruiting	`NCT03728114` - Effects of RIC on Cognitive Function and Blood Oxygen Levels in Unacclimatized Adult at High Altitude	N/A
Completed	`NCT01162863` - Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation	N/A
Completed	`NCT05570435` - Efficacy of Milk Product Supplemented With Bioactives in Lowering Post Meal Glucose Response	N/A
Recruiting	`NCT03713931` - PUMA Implementation 2
Completed	`NCT04443231` - Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation
Completed	`NCT05852340` - A Study to Assess Two Forms of The Study Medicine (Ritlecitinib) in Healthy Adult Participants	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

An Intervention to Develop Interface Tools for Nutrigenomics

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms